State Street Corporation (NYSE: STT) discloses 5.2% ownership in Pacira BioSciences
Rhea-AI Filing Summary
State Street Corporation reported beneficial ownership of common stock of Pacira BioSciences, Inc.. State Street and its investment adviser subsidiaries collectively beneficially own 2,059,977 shares of Pacira common stock, representing 5.2% of the outstanding class.
State Street reports no sole voting or dispositive power over Pacira shares. It has shared voting power over 1,944,697 shares and shared dispositive power over 2,059,977 shares, reflecting holdings managed through entities including SSGA Funds Management, Inc. and various State Street Global Advisors affiliates.
Positive
- None.
Negative
- None.
Key Figures
Shares beneficially owned: 2,059,977 shares
Percent of class: 5.2%
Shared voting power: 1,944,697 shares
+3 more
6 metrics
Shares beneficially owned
2,059,977 shares
Common stock of Pacira BioSciences beneficially owned by State Street Corporation
Percent of class
5.2%
Portion of Pacira BioSciences common stock class beneficially owned
Shared voting power
1,944,697 shares
Shares of Pacira common stock over which State Street has shared voting power
Shared dispositive power
2,059,977 shares
Shares of Pacira common stock over which State Street has shared dispositive power
Sole voting power
0 shares
Pacira shares over which State Street has sole power to vote
Sole dispositive power
0 shares
Pacira shares over which State Street has sole power to dispose
Key Terms
beneficially owned, shared voting power, shared dispositive power, Schedule 13G, +1 more
5 terms
beneficially owned financial
"Amount beneficially owned: 2059977.00"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Schedule 13G regulatory
"If a parent holding company has filed this schedule"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
parent holding company regulatory
"If a parent holding company has filed this schedule"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
How much of Pacira BioSciences (PCRX) stock does State Street Corporation own?
State Street Corporation beneficially owns 2,059,977 shares of Pacira BioSciences common stock, representing 5.2% of the outstanding class, as reported in its Schedule 13G passive ownership filing.
What dispositive power does State Street have over its Pacira BioSciences (PCRX) holdings?
State Street reports shared dispositive power over 2,059,977 shares of Pacira BioSciences common stock and no sole dispositive power, meaning decisions to sell or otherwise dispose are made on a shared basis.
Does State Street’s Pacira BioSciences (PCRX) stake exceed 5% of the company?
Yes. State Street’s beneficial ownership of 2,059,977 shares of Pacira BioSciences common stock represents 5.2% of the class, crossing the 5% threshold that requires a Schedule 13G ownership disclosure.